Atlas Trials

Evaluation of ACCS100 to Reduce Aflatoxin Exposure in Kenya

Clinical trial NCT02188953 · COMPLETED

Trial details

NCT number
NCT02188953
Sponsor
Kenya Medical Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Aflatoxicosis
Start date
2014-08-01
Primary completion
2014-09-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.